Table 1.
Patients (N = 42) | RT-PCR/NS1 antigen | IgM RDT or ELISA | IgG RDT | IgG ELISA | Interpretation |
---|---|---|---|---|---|
2 | NS1 negative | Negative | Negative | Negative | Never infected by DENV |
33* | NS1 negative | Negative | Negative | Positive | Past infection by DENV |
4 | RT-PCR and NS1 negative | Positive (no follow-up IV increase) | Negative | Positive | Recent secondary DENV infection |
#1: 4.8 to 4.1 | #1: 9.5 to 9.2 | ||||
#2: 2.8 to 0.5 | #2: 8.5 to 8.1 | ||||
#3: 1.6 to 0.8 | #3: 4.8 to 6.4 | ||||
#4: 3.7 to 1.6 | #4: 10.2 to 9.5 | ||||
3 | RT-PCR and NS1 negative | Positive (no follow-up IV increase) | Positive faint | Positive | Very recent secondary DENV infection, with high-titer IgG |
#1: 3.8 to 3.8 | #1: 17.1 to 16.6 | ||||
#2: 2.5 to 1.1 | #2: 12.3 to 11.5 | ||||
#3: 1.6 to 1.5 | #3: 12.5 to 12.3 |
DENV = dengue virus; IV = index value; RDT = rapid diagnostic test.
Ten patients in this group did not have follow-up sera. For patients with positive IgM and IgG, admission and follow-up IV are shown. Changes in both IgM and IgG interpretation were not noted in follow-up sera. There were no cases of current dengue coinfection.